Study: Statins may protect hep C patients from liver cancer

03/22/2013 | Reuters

The use of cholesterol-lowering statin drugs among patients with chronic hepatitis C was associated with a decreased risk of liver cancer, according to a study of around 261,000 patients in Taiwan. The reductions were modest, but the findings could address possible concerns about prescribing statins to patients with liver disease, a U.S. researcher commented. The study appeared in the Journal of Clinical Oncology.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA